The Maternal Well-Being Study (MWB)
The Maternal Well-Being Study: A Feasibility and Acceptability Trial of Postpartum Support Interventions
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
- To assess the local feasibility and acceptability of MamaMeals (home-delivered, nutritious meals) during the 4th trimester for mothers with peripartum food insecurity.
- To explore perceptions about receiving a medically-tailored meal delivery intervention during the 4th trimester (MamaMeals) among a diverse sample of peripartum individuals with food insecurity (FI).
- To assess through a randomized trial the potential efficacy of the MamaMeals (nutritious, home-delivered meals) and MamaMatters (ehealth postpartum support) interventions on peripartum mood disorders (primary outcome), postpartum cardiometabolic risk* (exploratory outcome), maternal wellbeing (exploratory outcome), and infant health (exploratory outcome) during the first 12 months following delivery. Hypothesis: Individuals who receive the MamaMeals + MamaMatters interventions will have lower Edinburgh Postpartum Depression Scale (EPDS) scores throughout the first 12 weeks postpartum compared to groups receiving only one intervention or the control group.
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Skyler McLaurin-Jiang, MD
- Phone Number: 806-414-9377
- Email: skyler.mclaurin@ttuhsc.edu
Study Contact Backup
- Name: Christine Garner, PhD
- Email: christine.garner@ttuhsc.edu
Study Locations
-
-
Texas
-
Amarillo, Texas, United States, 79106
- Texas Tech University Health Sciences Center
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- screen positive for food insecurity or qualify for any of the following governmental assistance programs Medicaid, WIC, SNAP, TANF,
- speak English,
- are between 20-40 completed weeks of pregnancy,
- are ages 18 years or older.
Exclusion Criteria:
- type 1 diabetes
- dietary contraindications (e.g., severe food allergy, or inflammatory bowel disease, celiac disease, chronic renal disease, bariatric surgery, short bowel syndrome)
- an active eating disorder (self-reported)
- hospitalization in the past 12 months for a mental health concern
- a history of postpartum psychosis
- Individuals with a history of being banned from any social media site will also be excluded.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Dual interventions
Receive both interventions: MamaMeals and MamaMatters Interventions
|
12 weeks of medically tailored meals
Other Names:
12 weeks of medically tailored meals and12 weeks of social media based support
Other Names:
|
|
Active Comparator: Meals intervention only
MamaMeals
|
12 weeks of medically tailored meals
Other Names:
|
|
Sham Comparator: Control
Wait-list control (received MamaMeals between 16-20 weeks postpartum) (after primary data collection time point)
|
Waitlist Control Group (no intervention for first 4 months and then receive MamaMeals between 16-20 weeks postpartum)
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
% of meals delivered to and consumed by subjects
Time Frame: 12 weeks
|
Feasibility of meal delivery social media support delivery
|
12 weeks
|
|
perception of the nutritious home delivered meal program
Time Frame: 12 weeks
|
subject engagement with interventions and perception of interventions
|
12 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
% of Edinburgh postnatal depression scale score >15 at 12 weeks postpartum
Time Frame: 12 weeks
|
12 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- A22-4290
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.